Record overview
Status and phase
Status: WITHDRAWN
Phase: PHASE1, PHASE2
Sponsor: Barbara Ann Karmanos Cancer Institute
Condition: Adult Brain Glioblastoma, Adult Gliosarcoma, Recurrent Brain Neoplasm
NCT02521090
EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
Due to lack of funding and a primary co-investigator of the trial leaving the institution.